GORDIAN
Dead / Abandoned — Abandoned — no statement of use filed (as of 18 Mar 2024)
What this means for you
This application is over — abandoned 18 Mar 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97384728
- Mark type
- Word mark
- Filed
- 27 Apr 2022
- Published for opposition
- 20 Jun 2023
- Abandoned
- 18 Mar 2024
- Attorney of record
- Tracy-Gene G. Durkin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, biological preparations, and cell- and gene-based therapy products to prevent and treat age-related cardiovascular disease, neurodegenerative disease, musculoskeletal disease, pulmonary disease, metabolic disease, diseases of the liver, macular degeneration and other ocular diseases, kidney disease, and cancer; pharmaceutical preparations, biological preparations, and cell- and gene-based therapy products to prevent and treat age-related cardiovascular disease, neurodegenerative disease, musculoskeletal disease, pulmonary disease, metabolic disease, diseases of the liver, macular degeneration and other ocular diseases, kidney disease, and cancer
- Class 042 — Scientific and technological services: Pharmaceutical and biological drug research and development services; research and development of pharmaceutical and biotechnology fields, namely, cell- and gene-based therapy research and development services; providing information about medical and scientific research on aging and complex multigenic diseases; providing information about medical and scientific research, namely, providing information on pharmaceutical drug, biological drug, and cell- and gene-based therapy research and development; providing scientific information on computational biology, machine learning, and bioinformatics
- Class 044 — Medical, beauty and agricultural services: Providing medical information on aging and complex multigenic diseases
Owner
- Gordian Biotechnology, San Francisco, CA, US
- Gordian Biotechnology, San Francisco, CA, US
Prosecution history
- 18 Mar 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 18 Mar 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Aug 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Jun 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Jun 2023 — PUBLISHED FOR OPPOSITION
- 31 May 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 May 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 May 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 May 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 May 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Feb 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Feb 2023 — NON-FINAL ACTION E-MAILED
- 15 Feb 2023 — NON-FINAL ACTION WRITTEN
- 14 Feb 2023 — ASSIGNED TO EXAMINER
- 03 May 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED